On August 26, 2026 Eikon Therapeutics, Inc. (Nasdaq: EIKN) ("Eikon"), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, reported that Roger M. Perlmutter, M.D., Ph.D., Chairman and Chief Executive Officer, and Freddie Bowie, Ph.D., Chief Financial Officer, will participate in two upcoming investor conferences taking place in September:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event:12th Annual Cantor Global Healthcare Conference
Location: New York, NY
Date & Time: September 10, 2026 at 2:10 pm ET
Format: Fireside Chat
Event: The Morgan Stanley 24th Annual Global Healthcare Conference
Location: New York, NY
Date & Time: September 15, 2026 at 4:05 pm ET
Format: Fireside Chat
Live audio/video webcasts of these presentations will be accessible through Eikon’s investor relations website at www.investors.eikontx.com, with an archived edition of the session available later that day and accessible for approximately 30 days after the live event.
(Press release, Eikon Therapeutics, AUG 26, 2026, View Source [SID1234670371])